UnitedHealth Buy Rating Affirmed Amidst Medicare Advantage Growth and Positive Sector Outlook
Scotiabank Maintains Sector Outperform on Chevron, Lowers Price Target to $180
Chevron Analyst Ratings
UBS Raises Price Target on Procter & Gamble to $191 From $183, Maintains Buy Rating
Goldman Sachs Keeps Their Buy Rating on JPMorgan Chase & Co. (JPM)
Chevron's Revised Earnings Forecast and Operational Challenges Prompt 'Hold' Rating
Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ)
BMO Capital Adjusts Exxon Mobil's Price Target to $125 From $127, Keeps Market Perform Rating
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Roche Holding AG (OtherRHHVF) and UnitedHealth (UNH)
Procter & Gamble Analyst Ratings
Citigroup Maintains Buy on Procter & Gamble, Raises Price Target to $190
Walmart Analyst Ratings
Piper Sandler Assumes Walmart at Overweight, Announces Price Target of $81
Goldman Sachs Adjusts Price Target on Exxon Mobil to $119 From $117
Neutral Rating on Exxon Mobil Amidst Acquisition Costs and Arbitration Concerns
Chevron's Growth and Valuation Appeal Affirm Buy Rating by Nitin Kumar CFA
Walmart Attracts Another Bull Rating as Piper Sandler Says the 2024 Rally Still Has Legs
Jefferies Keeps Their Buy Rating on Walmart (WMT)
BMO Capital Adjusts Price Target on Bank of America to $38 From $37, Keeps Market Perform Rating
BMO Capital Adjusts Price Target on JPMorgan Chase & Co. to $205 From $195, Keeps Market Perform Rating